Venous Thromboembolism (VTE) is the union of deep vein
thrombosis (DVT) and pulmonary embolism (PE); it’s an important cause of
morbidity and mortality with an estimated annual incidence of 0.67 to 1.0 per
1000 among the general population in western countries.
It is a polygenic disease with pathogenic contributions from
both genetic and environmental risk factors; according to Virchow’s triad, VTE
results from stasis hypercoagulability and the alteration in the blood vessel
wall.
This dichotomy has been challenged in recent years, it still
many unknown risk factors. Lipids and lipoproteins modulate the expression and/or the function of thrombotic,
fibrinolytic and rheological factors among patients with cardiovascular disease.
No comments:
Post a Comment